Aimmune Therapeutics

Provider of desensitization treatments for food allergies such as peanuts, egg and milk

placeSan Mateo, California, United States calendar_todayFounded 2011 groups250 employees language aimmune.com

Registered entities

Investor mix

11 investors on record; lead investors include RA Capital Management; 3 have since exited.

Investor typeCountShare
Venture capital19%
Private equity545%
Other / undisclosed545%
Coming soon